Titin-based adaptations of cardiac function Titin's I-band region functions as a molecular spring that together with the extracellular matrix (ECM) regulates the passive myocardial stiffness that is critically important for diastolic filling. Prevous work has shown that extensive differential splicing during postnatal development converts the giant fetal cardiac titin isoform into smaller and stiffer adult titin isoforms. The mechanical significance of postnatal isoform switching and the mechanical importance of changes in the ECM require in-depth study.
Aim 1 focuses on this topic in both the left ventricle (LV) and right ventricle (RV). For this work we made a mouse model in which a splice factor (RBM20) that is responsible for splicing stiff adult titins has been deleted and that expresses in adult myocardium titins similar in size to the giant fetal cardiac isoforms. This model mimics dilated cardiomyopathy (DCM) patients with RBM20 mutations in which fetal cardiac sized titins are expressed in the adult. Differential splicing and posttranslational modifications of titin will be studied, as well as changes in the ECM, and passive myocardial stiffness will be studied using multi-disciplinary experiments at a wide range of levels. Upregulating compliant titin isoforms might also affect cardiac hypertrophy in both concentric and eccentric remodeling (Aim 2). Recent work indicated that a stretch-sensing signalosome binds to titin that triggers hypertrophy in response to an increase in strain. This important concept requires critical testing and in-depth study. The expression of compliant titins in our new KO mouse model predict that hypertrophy is attenuated (because titin's strain is reduced) and that this contributes to the DCM phenotype.
Aim 2 will test this by studying hypertrophy in response to increased afterload (transverse aortic constriction (TAC) model) or increased preload (aortocaval fistula (ACF) surgery model), two contrasting models that result in the distinct concentric or eccentric hypertrophy phenotypes, respectively. Titin isoform switching is also likely to affect systole as titin- based passive tenson has been proposed to play an important role in the Frank-Starling mechanism (FSM) of the heart, i.e., the increase in contractility with length. Although the FSM is critical for adjusting stroke volume to match venous return, the mechanism(s) underlying the FSM have remained elusive.
Aim 3 will test the role that titin plays using the RBM20 mouse model that expresses giant titin isoforms in the adult heart and that provides an exciting opportunity to study the effet of a reduction in titin-based passive tension on the FSM under physiological conditions. Experiments will be performed at the cell, tissue, and whole heart levels. A novel mouse model was made for this application, novel reagents were developed, a strong team is in place, and results from pilot studies support the proposal's guiding hypotheses. The proposed studies will provide insights in the importance of titin and the ECM in diastolic filling, systolic performance, and hypertrophy signaling, topics of great interest from a basic science viewpoint and that have high clinical significance for pediatric heart disease, heart failure in adults, and hypertrophic ad dilated cardiomyopathy.
An important focus of this proposal is on the role of titin, the largest protein known, in diastolic filling during neonatal development, and the proposed studies will examine isoform switching and post-translational modification of titin, relative to the change in ECM, in both the left and right ventricles of the heart. The role of titin in the heart's pump function and in hypertrophy of the muscular wall of the heart's pumping chambers will also be studied. This work will contribute to the understanding of mechanisms giving rise to diastolic dysfunction and reduced pump function in heart failure patients, and it will contribute to understanding of the disease mechanisms of heart failure patients with mutations in RBM20.
|Jeong, Mark Y; Lin, Ying H; Wennersten, Sara A et al. (2018) Histone deacetylase activity governs diastolic dysfunction through a nongenomic mechanism. Sci Transl Med 10:|
|Ma, Weikang; Gong, Henry; Kiss, Balázs et al. (2018) Thick-Filament Extensibility in Intact Skeletal Muscle. Biophys J 115:1580-1588|
|Methawasin, Mei; Granzier, Henk (2018) Softening the Stressed Giant Titin in Diabetes Mellitus. Circ Res 123:315-317|
|Oates, Emily C; Jones, Kristi J; Donkervoort, Sandra et al. (2018) Congenital Titinopathy: Comprehensive characterization and pathogenic insights. Ann Neurol 83:1105-1124|
|Tonino, Paola; Kiss, Balazs; Strom, Josh et al. (2017) The giant protein titin regulates the length of the striated muscle thick filament. Nat Commun 8:1041|
|Methawasin, Mei; Granzier, Henk (2017) Response by Methawasin and Granzier to Letter Regarding Article, ""Experimentally Increasing the Compliance of Titin Through RNA Binding Motif-20 (RBM20) Inhibition Improves Diastolic Function in a Mouse Model of Heart Failure With Preserved Ejection Frac Circulation 135:e681-e682|
|Kellermayer, Dalma; Smith 3rd, John E; Granzier, Henk (2017) Novex-3, the tiny titin of muscle. Biophys Rev 9:201-206|
|Bull, Mathew; Methawasin, Mei; Strom, Joshua et al. (2016) Alternative Splicing of Titin Restores Diastolic Function in an HFpEF-Like Genetic Murine Model (Ttn?IAjxn). Circ Res 119:764-72|
|Methawasin, Mei; Strom, Joshua G; Slater, Rebecca E et al. (2016) Experimentally Increasing the Compliance of Titin Through RNA Binding Motif-20 (RBM20) Inhibition Improves Diastolic Function In a Mouse Model of Heart Failure With Preserved Ejection Fraction. Circulation 134:1085-1099|
|Pappas, Christopher T; Mayfield, Rachel M; Henderson, Christine et al. (2015) Knockout of Lmod2 results in shorter thin filaments followed by dilated cardiomyopathy and juvenile lethality. Proc Natl Acad Sci U S A 112:13573-8|
Showing the most recent 10 out of 17 publications